Efficacy and Safety of Two Regimens of Anti-VEGF Therapy in Chinese Patients With Polypoidal Choroidal Vasculopathy

NCT04380974 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Polypoidal Choroidal Vasculopathy

Interventions

PROCEDURE: OCTA plus OCT guided 3+PRN regimen
PROCEDURE: OCT guided 3+PRN regimen
DRUG: Anti-VEGF drug

Sponsor

Xiaodong Sun

Collaborators

[object Object]
[object Object]